2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
6
Polycystic Ovary Syndrome
5
Obesity
5
Neoplasms
3
Motor Activity
3
Ovarian Diseases
2
Ovarian Cysts
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Feeding Behavior
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neuroendocrine Tumors
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Growth Hormone-Secreting Pituitary Adenoma
1
Fibrosis
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Interventions
fludarabine phosphate
25
Cyclophosphamide
24
Peripheral Blood Stem Cell Transplantation
23
Busulfan
17
Tacrolimus
15
Methotrexate
13
Cyclosporine
13
ruxolitinib
12
Whole-Body Irradiation
12
Mycophenolic Acid
12
Antilymphocyte Serum
11
Filgrastim
8
Decitabine
7
fludarabine
6
Etoposide
6
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
6
peginterferon alfa-2a
5
Radiotherapy
5
Methylprednisolone
5
Cytarabine
5
Carboplatin
5
Prednisone
4
Melphalan
4
Flow Cytometry
4
Biopsy
4
Aspirin
4
givinostat hydrochloride
3
givinostat
3
bomedemstat
3
anagrelide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombocythemia, Essential
×
Diet, Mediterranean
×
Clear all
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled